Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Investigation of Patients With Parkinson's Disease by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells

NCT03550183 is registered in ClinicalTrials.gov with Hebei Newtherapy BIo-Pharma technology Co., Ltd. as lead sponsor.

NCT NCT03550183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03550183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Investigation of Patients With Parkinson's Disease by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells
Lead sponsor
Hebei Newtherapy BIo-Pharma technology Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
January 10, 2018
Completion date
December 30, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease